• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在西班牙,纤维肌痛患者的资源利用和医疗保健费用。

Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.

机构信息

Unidad de Reumatología, Instituto Provincial de Rehabilitación, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

出版信息

Clin Exp Rheumatol. 2009 Sep-Oct;27(5 Suppl 56):S39-45.

PMID:20074438
Abstract

OBJECTIVE

Fibromyalgia (FM) patients have been regarded as great utilizers of health resources, with important related costs. The aim of this study is to describe health care resource utilisation and related costs of FM from the perspective of the National Health System in Spain.

PATIENTS AND METHODS

A cross-sectional multicenter study was conducted on FM patients based on a patient interview. Data about demographic and clinical variables, physical examination, self-perceived health, psychosocial variables and health resource utilisation, were collected. Direct and indirect costs were calculated, and a correlational study between costs and clinical variables was performed.

RESULTS

Three-hundred and one patients were studied. During the year 2006 the mean total cost per patient per year was 9,982 Euros, of which 3,245.8 (32.5%) corresponded to health care costs and 6,736.2 (67.5%) to indirect costs attributable to productivity losses. Non-drug therapies accounted for the largest proportion of the health care costs, three times greater than the drug treatment. Patients with higher total costs showed the greatest disease involvement. The variables associated to the total health care costs were functional capacity, depression, comorbidities and age. Patients with permanent working disability were the greatest resource utilizers.

CONCLUSIONS

FM patients with higher costs show the greatest disease involvement. Direct and indirect costs are well correlated to disease severity. The indirect costs account for most of the economic burden of FM and approximately double the health care costs. Patients with permanent working disability present more severe disease and generate greater health care costs.

摘要

目的

纤维肌痛(FM)患者被认为是大量利用卫生资源的人群,存在重要的相关费用。本研究旨在从西班牙国家卫生系统的角度描述 FM 患者的卫生保健资源利用情况和相关费用。

患者和方法

对基于患者访谈的 FM 患者进行了一项横断面多中心研究。收集了人口统计学和临床变量、体格检查、自我感知健康、心理社会变量以及卫生资源利用的数据。计算了直接和间接费用,并对费用与临床变量之间的相关性进行了研究。

结果

共研究了 301 名患者。2006 年,每位患者每年的平均总费用为 9982 欧元,其中 3245.8 欧元(32.5%)为卫生保健费用,6736.2 欧元(67.5%)为因生产力损失导致的间接费用。非药物治疗占卫生保健费用的比例最大,是药物治疗的三倍。总费用较高的患者表现出更大的疾病负担。与总卫生保健费用相关的变量是功能能力、抑郁、合并症和年龄。有永久性工作残疾的患者是最大的资源利用者。

结论

费用较高的 FM 患者表现出更大的疾病负担。直接和间接费用与疾病严重程度密切相关。间接费用占 FM 经济负担的大部分,约为卫生保健费用的两倍。有永久性工作残疾的患者疾病更严重,产生的卫生保健费用更高。

相似文献

1
Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.在西班牙,纤维肌痛患者的资源利用和医疗保健费用。
Clin Exp Rheumatol. 2009 Sep-Oct;27(5 Suppl 56):S39-45.
2
Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.纤维肌痛严重程度对健康经济成本的影响:一项来自欧洲的横断面研究结果。
Appl Health Econ Health Policy. 2011 Mar 1;9(2):125-36. doi: 10.2165/11535250-000000000-00000.
3
Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice.在常规医疗实践中治疗纤维肌痛症患者后的前瞻性研究:医疗资源使用情况和经济成本。
Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):31-8. Epub 2012 Dec 14.
4
The costs associated with sleep symptoms among patients with fibromyalgia.纤维肌痛患者睡眠症状相关的费用。
Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):131-9. doi: 10.1586/erp.12.82.
5
Cost of illness and illness perceptions in patients with fibromyalgia.纤维肌痛患者的疾病成本与疾病认知
Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S74-82. Epub 2016 Feb 8.
6
Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial.在一项随机实用试验中,为最近诊断为纤维肌痛的患者提供三种不同干预措施之一后的资源利用和直接成本。
Clin Rheumatol. 2016 May;35(5):1307-15. doi: 10.1007/s10067-015-3067-y. Epub 2015 Sep 26.
7
The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.轻度、中度和重度纤维肌痛的比较经济负担:一项针对美国工作年龄成年人的回顾性病历审查和横断面调查结果
J Manag Care Pharm. 2012 Jul-Aug;18(6):415-26. doi: 10.18553/jmcp.2012.18.6.415.
8
Health status and costs of ambulatory patients with multiple sclerosis in Hungary.匈牙利多发性硬化症门诊患者的健康状况和费用
Ideggyogy Sz. 2012 Sep 30;65(9-10):316-24.
9
Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.法国纤维肌痛患者的社会和个体疾病负担:疾病严重程度与 OMERACT 核心领域的关系。
BMC Musculoskelet Disord. 2012 Feb 17;13:22. doi: 10.1186/1471-2474-13-22.
10
The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.美国慢性广泛性疼痛和纤维肌痛的比较负担
Pain Pract. 2016 Jun;16(5):565-79. doi: 10.1111/papr.12302. Epub 2015 May 16.

引用本文的文献

1
Social costs associated with fibromyalgia in Spain.西班牙纤维肌痛相关的社会成本。
Health Econ Rev. 2024 Jul 13;14(1):51. doi: 10.1186/s13561-024-00527-1.
2
Cost-utility of a multicomponent intervention for fibromyalgia versus usual care: a pragmatic randomised controlled trial.纤维肌痛多组分干预与常规护理的成本-效用比较:一项实用随机对照试验。
J Rehabil Med. 2023 Dec 19;55:jrm12361. doi: 10.2340/jrm.v55.12361.
3
Psychological Outcomes and Quality of Life of Fibromyalgia Patients with Vitamin D Supplementation-A Meta-Analysis.
补充维生素D的纤维肌痛患者的心理结局和生活质量——一项荟萃分析
J Clin Med. 2023 Apr 6;12(7):2750. doi: 10.3390/jcm12072750.
4
Patients' Lived Experience in a Multicomponent Intervention for Fibromyalgia Syndrome in Primary Care: A Qualitative Interview Study.患者在初级保健中接受纤维肌痛综合征多组分干预的体验:定性访谈研究。
Int J Environ Res Public Health. 2022 Oct 15;19(20):13322. doi: 10.3390/ijerph192013322.
5
UK healthcare services for people with fibromyalgia: results from two web-based national surveys (the PACFiND study).英国纤维肌痛患者的医疗保健服务:两项基于网络的全国性调查(PACFiND 研究)的结果。
BMC Health Serv Res. 2022 Aug 3;22(1):989. doi: 10.1186/s12913-022-08324-4.
6
Cost-utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial.多组分干预纤维肌痛综合征在初级保健与常规临床实践中的成本效用分析:一项随机对照试验的经济学评价研究方案。
BMJ Open. 2021 Feb 5;11(2):e043562. doi: 10.1136/bmjopen-2020-043562.
7
Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis.治疗纤维肌痛患者疼痛减轻和生活质量改善的相关性:系统评价和荟萃分析。
JAMA Intern Med. 2021 Jan 1;181(1):104-112. doi: 10.1001/jamainternmed.2020.5651.
8
Low-Intensity Physical Exercise Improves Pain Catastrophizing and Other Psychological and Physical Aspects in Women with Fibromyalgia: A Randomized Controlled Trial.低强度体育锻炼改善纤维肌痛女性的疼痛灾难化和其他心理及生理方面:一项随机对照试验。
Int J Environ Res Public Health. 2020 May 21;17(10):3634. doi: 10.3390/ijerph17103634.
9
Strength Assessment Under Dual Task Conditions in Women with Fibromyalgia: A Test-Retest Reliability Study.纤维肌痛女性双重任务条件下的力量评估:测试-重测信度研究。
Int J Environ Res Public Health. 2019 Dec 6;16(24):4971. doi: 10.3390/ijerph16244971.
10
The effect of cryotherapy on fibromyalgia: a randomised clinical trial carried out in a cryosauna cabin.冷冻疗法对纤维肌痛的影响:在 cryosauna 舱内进行的随机临床试验。
Rheumatol Int. 2018 Dec;38(12):2243-2250. doi: 10.1007/s00296-018-4176-0. Epub 2018 Oct 23.